𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomized, controlled trial*1, *2

✍ Scribed by MANESIS, E

Book ID
122051806
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
1008 KB
Volume
21
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of hepatocellular carcinoma wi
Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: A randomized, controlled trial
✍ Emanuel K. Manesis; Gregory Giannoulis; Pavlos Zoumboulis; Irini Vafiadou; Steph πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 961 KB

We tested the hypothesis that a combination of sex hormone suppression and inhibition of their target receptors might improve survival for patients with hepatocellular carcinoma (HCC). Eighty-five consequent, previously untreated HCC patients with inoperable disease, were randomized to receive the l

Phase 1-2 trial of PTK787/ZK222584 combi
Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma : Implication for antiangiogenic approach to hepatocellular carcinoma
✍ Thomas Yau; Pierre Chan; Roberta Pang; Kelvin Ng; S. T. Fan; Ronnie T. Poon πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 265 KB

## Abstract ## BACKGROUND: This phase 1‐2 trial assessed the efficacy and tolerability of an oral angiogenesis inhibitorβ€”PTK787/ZK222584 (PTK)β€”in combination with intravenous doxorubicin for the treatment of advanced hepatocellular carcinoma (HCC) patients. ## METHODS: In phase 1, advanced HCC p